Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | N2UJM5NBF6 |
InChI Key | DTXXSJZBSTYZKE-ZDQKKZTESA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C26H42O4 |
Molecular Weight | 418.62 |
AlogP | 4.69 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 6.0 |
Polar Surface Area | 69.92 |
Molecular species | NEUTRAL |
Aromatic Rings | 0.0 |
Heavy Atoms | 30.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group I
Nuclear hormone receptor subfamily 1 group I member 1
|
1-160 | - | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Hyperparathyroidism, Secondary | 3 | D006962 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 103909-75-7 |
ChEBI | 31801 |
ChEMBL | CHEMBL333950 |
DrugCentral | 1638 |
EPA CompTox | DTXSID4048648 |
FDA SRS | N2UJM5NBF6 |
Guide to Pharmacology | 2784 |
PDB | MCZ |
PubChem | 6398761 |
SureChEMBL | SCHEMBL17975926 |
ZINC | ZINC000004474617 |